Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.
Article Title
Resmetirom and New Agents for Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review of Phase 3 Data on Histologic and Clinical Outcomes
Authored by
Ibrahim Hussain Alzahib
Internal Medicine Department, King Salman Armed Hospital, Tabuk, Saudi Arabia.
Ensaf Adnan Mousa AlBokhari
Internal Medicine Department, King Salman Armed Hospital, Tabuk, Saudi Arabia.
Khalid Hazim A. Alotaibi
Tabuk University, Tabuk, Saudi Arabia.
Mashael Zayed M. AlBalawi
Internal Medicine Department, King Salman Armed Hospital, Tabuk, Saudi Arabia.
Bader Abdulrahman Husayyan Alanazi
King Salman Military Hospital, Tabuk, Saudi Arabia.
Metab Ali Saeed Alasmari
King Salman Military Hospital, Tabuk, Saudi Arabia.
Mohammed Hussain Abdulrahman Alzahib
King Salman Military Hospital, Tabuk, Saudi Arabia.
Norah Saad Jubran Alkahtani
Tabuk Health Cluster, Tabuk, Saudi Arabia.